MAM
Mark Asset Management’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-40,370
| Closed | -$1.8M | – | 45 |
|
|
2021
Q4 | $1.8M | Buy |
40,370
+19,841
| +97% | +$885K | 0.2% | 36 |
|
|
2021
Q3 | $1.04M | Sell |
20,529
-18,310
| -47% | -$924K | 0.11% | 41 |
|
|
2021
Q2 | $3.05M | Sell |
38,839
-73,080
| -65% | -$5.73M | 0.38% | 34 |
|
|
2021
Q1 | $6.39M | Sell |
111,919
-60,121
| -35% | -$3.43M | 0.96% | 29 |
|
|
2020
Q4 | $14.4M | Sell |
172,040
-7,389
| -4% | -$619K | 1.73% | 16 |
|
|
2020
Q3 | $6.43M | Sell |
179,429
-1,069
| -0.6% | -$38.3K | 0.93% | 27 |
|
|
2020
Q2 | $4.36M | Buy |
180,498
+17,976
| +11% | +$435K | 0.82% | 30 |
|
|
2020
Q1 | $2.85M | Buy |
162,522
+95,965
| +144% | +$1.68M | 0.66% | 30 |
|
|
2019
Q4 | $1.16M | Sell |
66,557
-2,307
| -3% | -$40.2K | 0.19% | 37 |
|
|
2019
Q3 | $1.06M | Sell |
68,864
-1,668
| -2% | -$25.6K | 0.26% | 35 |
|
|
2019
Q2 | $1.46M | Hold |
70,532
| – | – | 0.34% | 35 |
|
|
2019
Q1 | $1.64M | Buy |
70,532
+50,632
| +254% | +$1.18M | 0.36% | 33 |
|
|
2018
Q4 | $411K | Buy |
+19,900
| New | +$411K | 0.11% | 43 |
|